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Abstract  Bladder  cancer  occurs  frequently  and  is  serious.  Although  ultrasound  and  CT
examination  are  essential,  magnetic  resonance  imaging  is  more  effective  for  staging  large
tumours and  in  atypical  cases,  in  particular  submucosal  lesions.  CT  and  MRI  are  equallyMRI;
Tumour  extension;
Functional  MRI
effective  in  examining  the  lymph  nodes.  The  examination  technique  is  simple.  The  prospects
for using  MRI,  in  particular  with  diffusion  imaging,  are  being  evaluated.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Magnetic  resonance  imaging  (MRI)  is  the  best  imaging  technique  for  exploring  the  pelvic
cavity  because  of  its  high  contrast  resolution  and  its  optimal  spatial  resolution,  due  to
the  current  phased  array  coils  with  parallel  imaging  techniques.  Diagnosis  of  a  bladder
tumour,  suspected  from  the  ultrasound  examination,  is  conﬁrmed  by  cystoscopy  and
histopathological  analysis  of  the  material  sampled,  which  provides  information  regarding
the  histological  type  and  how  deeply  the  tumour  extends.  The  main  role  for  MRI  is  in
pre-treatment  staging,  but  it  is  also  important  in  post-therapeutic  monitoring  and  in
atypical  cases  or  certain  rarer  circumstances.
Technique [1—5]
The  examination  is  performed  with  a  phased  array  coil.
The  bladder  must  be  moderately  full.  If  the  bladder  is  considerably  distended,  apart
from  discomfort  for  the  patient  and  the  consequent  risk  of  uncontrollable  movements,
the  thinness  of  the  bladder  wall  makes  analysing  it  impossible.  On  the  other  hand,  if  the
bladder  is  empty,  the  tumour  will  be  barely  visible.
Injection  of  an  antispasmodic  (Glucagen®) just  before  starting  the  examination  reduces
artefacts  due  to  movement  of  the  digestive  tube;  it  is  essential  in  slim  patients  where  the
E-mail address: catherine.roy@chru-strasbourg.fr.
2211-5684/$ — see front matter © 2012 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
doi:10.1016/j.diii.2012.01.013
2 C.  Roy
l
w
s
o
t
p
(
p
t
o
w
a
a
(
a
a
t
b
t
[
S
T
I
s
o
r
f
T
I
t
t
P
c
c
F
t
H
Box  1  UICC  2002  TNM  classiﬁcation.
T  Primary  tumour
Tx:  primary  tumour  cannot  be  assessed
T0:  no  evidence  of  primary  tumour
Ta:  non-invasive  papillary  carcinoma
Tis:  carcinoma  in  situ:  ﬂat  tumour
T1:  tumour  invades  subepithelial  connective
tissue
T2:  tumour  invades  muscularis  propria
pT2a:  tumour  invades  superﬁcial  muscularis
propria  (inner  half)
pT2b:  tumour  invades  deep  muscularis  propria
(outer  half)
T3:  tumour  invades  perivesical  tissue
pT3a:  microscopic  invasion
pT3b:  macroscopic  extravesical  invasion
T4:  tumour  invades  a  neighbouring  structure
T4a:  tumour  invades  prostatic  stroma,  vagina  or
uterus
T4b:  tumour  invades  pelvic  or  abdominal  wall
N  Regional  lymph  nodes
Nx:  lymph  nodes  cannot  be  assessed
N0:  no  regional  lymph  node  metastasis
N1:  lymph  node  metastasis  only  <  2  cm
N2:  lymph  node  metastasis  only  >  2  cm  and  <  5  cm
or  multiple  lymph  node  metastases  <  5  cm
N3:  lymph  node  metastasis  >  5  cm
M  Distant  metastases
Mx:  metastasis  cannot  be  assessed
M0:  no  distant  metastasis
M1:  distant  metastasis
1: mucosa;  2:  sub-mucosa;  3:  superﬁcial  muscle
as  a  linear  structure  with  poorly  deﬁned  contours,  with  a98  
oops  of  the  small  intestine  are  in  contact  with  the  bladder
all.  It  is  effective  for  about  20  minutes.
Slice  thickness  varies  from  3  to  4  mm.
The  examination  combines  a  number  of  T2-weighted
pin-echo  sequences  (T2-weighted  SE)  in  at  least  three
rthogonal  and/or  oblique  planes,  so  as  to  be  perpendicular
o  the  wall  of  the  tumour  to  reduce  the  partial  volume
henomenon  to  a  minimum,  and  a  T1-weighted  spin-echo
T1-weighted  SE)  axial  sequence  for  the  lymph  node  axes,
ossibly  with  the  addition  of  another  fat  saturation  plane
o  be  able  to  assess  the  contours  of  the  bladder.  A  tumour
f  the  dome  is  explored  in  the  sagittal  and  frontal  planes,
hile  a  tumour  of  the  lateral  surface  is  explored  in  the
xial  and  frontal  planes.  The  tumour  and  the  bladder  wall
re  analysed  by  a  dynamic  T1-weighted  gradient-echo
T1-weighted  GE)  sequence  with  injection  of  gadolinium
nd  temporal  resolution  lower  than  or  equal  to  20  seconds,
t  best  with  fat  saturation  and  orientation  perpendicular  to
he  implantation  base  of  the  tumour.
It  has  been  suggested  that  an  endorectal  coil  should
e  used  for  tumours  of  the  base,  the  trigone  and
he  posterior  wall.  Diffusion  imaging  is  being  evaluated
1].
emeiology of tumour of the bladder
1-weighted sequence
n  T1-weighted  SE,  the  tumour  has  an  intermediate  to  low
ignal,  similar  to  that  of  the  bladder  wall  (Box  1).  It  is  iso-
r  slightly  hyperintense  relative  to  muscle,  hyperintense
elative  to  urine  and  hypointense  relative  to  perivesical
at.
2-weighted sequence
n  T2-weighted  SE,  the  signal  from  the  tumour  is  much  lower
han  the  signal  from  urine,  is  higher  than  the  hyposignal  from
he  wall  and  lower  or  the  same  as  that  of  fat  (Figs.  1  and  2).
olypoid  tumours  have  an  implantation  pedicle  containing
onnective  tissue  and  capillaries,  as  well  as  inﬂammatory
ells  with  oedema.  This  pedicle  is  visible  in  75%  of  cases
igure 1. MRI of a tumour of the bladder, stage pT1: a: T2-weighted 
he left part of the trigone. Hyposignal from the intact muscle of the w
yposignal from the intact muscle part.
l
b
tlayer;  4:  deep  muscle  layer.  This  classiﬁcation  only
concerns  urothelial  carcinomas  of  the  bladder.SE, axial plane. Polypoid mass with intermediate signal located in
all. No dilatation of the ureter; b: T2-weighted SE, frontal plane.
ower  signal  than  that  of  the  tumour  in  T2  weighting,  and
ecomes  enhanced  later  than  the  tumour  following  injec-
ion,  which  shows  its  ﬁbrous  nature.  The  smooth  muscle  part
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Figure 2. MRI of a tumour of the bladder, stage pT3b: a: T2-weighted SE, axial plane. Polypoid mass of the left part of the trigone, with
rupture of the hyposignal from the wall and invasion of the fat in the space between the seminal vesicles (black arrow); b: T2-weighted SE,
frontal plane. The tumour is invading the muscle and extends beyond the limits of the bladder into the fat, without involving the digestive
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ptube (black arrow).
of  the  wall  is  sometimes  attracted  towards  the  implantation
pedicle  (Fig.  3).
The  presence  of  a  hyposignal  border  (muscle  layer)  at
the  base  of  the  tumour  indicates  a  stage  T1  tumour.  An
irregular  internal  contour  indicates  a  stage  T2a  tumour  and
the  hyposignal  border  being  interrupted  by  a  hypersignal,
with  no  inﬁltration  of  perivesical  fat,  indicates  a  stage  T2b
tumour.  Finally,  a  lesion  with  an  irregular  internal  contour
and  striations  in  the  perivesical  fat  is  evidence  of  a stage
T3b  tumour  (Figs.  1  and  2).
T1-weighted sequence with injection of
gadolinium
The  injection  of  a  contrast  agent  increases  the  sensitivity
of  MRI  for  detecting  small  tumours  and  improves  analysis  of
parietal  invasion.  Since  the  tumour  is  hypervascularised,  it
takes  up  the  contrast  agent  early  and  intensely,  with  more
rapid  wash-out  than  in  non-tumour  tissue.  Consequently  the
tumour  can  be  identiﬁed  by  its  hypersignal  between  15  to
25  seconds  following  injection,  while  the  signal  from  the
muscle  layer  remains  hypointense  (Fig.  4).  After  that,  the
signal  from  the  tumour  diminishes,  the  signal  from  the  wall
increases  and  the  high  intensity  of  the  contrast  agent  in  the
bladder  will  mask  small  tumours.
The  intensity  of  enhancement  is  proportional  to  the
degree  of  tumour  vascularisation;  it  reﬂects  the  density  of
the  microvessels  [6—11]. In  theory,  the  tumour  is  enhanced
earlier  than  oedema  or  granulation  tissue,  but  there  are  sev-
eral  causes  of  false-positives  that  one  needs  to  be  aware
of:  inﬂammatory  peritumoral  neovascularisation  with  no
histological  extension,  post-biopsy  restructuring,  and  after
endovesical  instillation,  or  even  post-radiotherapy  ﬁbrosis,
if  the  examination  is  conducted  too  soon  (less  than  3  months
T
s
tfterwards).  An  additional  difﬁculty  is  due  to  the  frequently
typical  tumours  (60%  of  cases)  which  give  a  signal  identical
o  or  barely  different  from  the  signal  from  the  wall,  or  are
ven  surrounded  by  a  hyposignal  border  in  T2-weighted  SE
r  in  the  injection  sequence  [6—10].
The  spatial  resolution  of  current  machines  makes  it  pos-
ible  to  visualise  polypoid  tumours  that  are  7  to  8  mm  in  size
r  more.
In  the  literature,  dynamic  sequences  with  injection  of
ontrast  agent  are  variably  effective  ranging  from  75  to  92%
or  differentiating  a  T1  stage  or  below  from  a  T2  stage  or
igher,  with  overall  efﬁcacy  for  all  types  of  52  to  93%  [9].  In
ayashi’s  study  [6]  with  an  endorectal  coil  for  better  analysis
f  the  submucosal  layer,  efﬁcacy  in  differentiating  a  T1  stage
r  under  from  a  T2  stage  or  more  was  87%.  Tekes  et  al.  [7]
eport  sensitivity  and  speciﬁcity  of  86%  and  84%  respectively
or  distinguishing  a  pT2  stage  or  below  from  a  pT3  stage  or
igher  (Fig.  4).  Using  the  three  types  of  sequence  combined,
iagnostic  efﬁcacy  of  stage  pT3  or  above  is  94%  [8].
iffusion imaging
iffusion  imaging  has  excellent  sensitivity  for  detecting
esions,  with,  as  in  any  tumour  process,  slowing  of  diffusion
een  in  diffusion  imaging  as  a  hypersignal  and  a  low  apparent
iffusion  coefﬁcient  (ADC)  (<  1000  ×  10−3 mm3/sec),  easy  to
etect  on  the  ADC  map  (Figs.  5  and  6).  In  the  literature,
t  is  reported  that  the  intensity  of  the  fall  in  the  ADC  pro-
ides  useful  information  for  evaluating  the  tumour  stage,  in
articular  for  differentiating  stage  T1  or  below  from  stage
2  or  higher.  The  ADC  value  of  G3  grade  tumours  would  be
igniﬁcantly  lower  than  values  for  G1  and  G2  grades  [10].
As  in  CT,  ureteral  dilatation  indicates  parietal  invasion  of
he  meatus.  Identifying  an  intraluminal  tumour  is  facilitated
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Figure 3. MRI of a large volume right bladder tumour invading the wall: stage pT3b: a: T2-weighted SE, axial plane. The signal from the
tumour is low, contrasting with the hypersignal from the urine. Note how the implantation pedicle can be seen, that the perivesical fat is
b wall 
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Ueing attracted (black arrow) and the normal hyposignal from the 
nd the implantation pedicle are easily visible (white arrow); c: uro
y  injection,  but  thickening  of  the  circumference  of  the  wall
s  not  speciﬁc  to  tumoral  invasion.
xtension to neighbouring organs
2-weighted sequence
he  T2-weighted  SE  sequence  provides  excellent  contrast
ith  the  zonal  anatomy  of  the  various  pelvic  organs  and
he  pelvic  wall  (Fig.  7).  Analysis  in  the  sagittal  or  frontal
lanes  is  best  for  staging,  particularly  towards  the  pelvic
alls  and  ﬂoor.  A  lesion  extending  into  a  neighbouring  organ
r  the  pelvic  wall  in  T2-weighted  SE  and  following  injection
ndicates  stage  T4.
eminal vesicles
nvasion  of  the  seminal  vesicles  is  judged  using  morpho-
ogical  criteria  in  T1-weighted  SE,  because  their  signal  is
ot  modiﬁed:  hypertrophy  of  a  vesicle  with  replacement
f  the  interseminal  vesicle  fatty  hypersignal  by  a  hyposig-
al.  In  T2-weighted  SE,  there  is  a  localised  or  diffuse  fall
n  the  hypersignal  from  the  seminal  vesicle,  replaced  by  a
E
a
i
minterrupted; b: T2-weighted SE, frontal plane. Invasion of the fat
. Attraction of the wall with respect to the lacuna (white arrow).
ignal  which  evolves  on  injection  just  like  the  signal  from
he  tumour.  The  sensitivity  of  this  signal  is  good,  but  its
peciﬁcity  is  mediocre  because  the  seminal  vesicles  can  pro-
uce  a  weak  signal  in  certain  physiological  circumstances
an  elderly  patient,  severe  alcoholism,  a  history  of  infec-
ion,  local  radiotherapy  or  amyloidosis  of  the  vesicles).  In
hese  cases,  the  hyposignal  is  diffuse  and  bilateral,  and  the
esicles  are  small  in  size.
rostate
nvasion  of  the  prostate  is  assessed  in  the  frontal  or  sagittal
lane  and  in  T2-weighted  SE,  based  on  two  criteria:  dis-
ppearance  of  the  clear  limit  between  the  bladder  and  the
rostate,  and  a  mass  in  the  parenchyma  of  the  prostate  with
 signal  identical  to  that  from  the  bladder  tumour.  Urethral
nvasion  is  impossible  to  conﬁrm.
terus and vaginaxtension  to  the  vaginal  fornix,  cervix  and  uterine  body
re  studied  in  the  sagittal  plane  in  T2-weighted  SE.  The
nvasion  criteria  are  identical  to  the  criteria  suggested  for
en.
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Figure 4. MRI of a tumour of the trigone, stage pT4a, revealed by acute urine retention: a: T2-weighted SE, sagittal plane. Tissue
thickening of the trigone with disappearance of the hyposignal from the wall (black arrow) and inﬁltration of the anterior wall of the vagina.
Note the thickening of the superior posterior wall (white arrowhead); b: T1-weighted GE with injection of contrast agent; 15 seconds; sagittal
plane. The tumour mass of the trigone is interrupting the muscle wall and inﬁltrating the vesicovaginal space then the anterior vaginal
wall (white arrow). Linear enhancement on the posterior surface of the dome, without parietal inﬁltration on injection of contrast agent,
corresponding to stage pT1 (white arrowhead); c: T2-weighted SE, axial plane. The mass is invading the two ureteral meatus (black arrows);
d: b-1000 diffusion sequence. Hypersignal from the tumour (white arrow); e: ADC map of the diffusion sequence. Slowing of diffusion in the
tumour process (white arrow).
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Figure 5. MRI of a tumour of the trigone, stage pT4a. b-1000 diffusion sequence: a: hypersignal from the tumour (white arrow);
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white arrow).
elvic wall
nvasion  of  the  pelvic  wall  is  assessed  in  T2-weighted  SE.
oss  of  the  fatty  border  between  two  structures  does  not
ean  inﬁltration.  The  only  reliable  criterion  is  the  existence
n  the  muscle  of  a  signal  identical  to  the  signal  from  the
umour.  Disappearance  of  the  cortical  bone  with  medullary
nﬁltration  indicates  extension  into  the  bone.
The  overall  reliability  of  MRI  varies  on  the  whole  from  73
o  96%  for  local  tumour  staging.
ro-MRI
nalysis  of  the  upper  excretory  system  uses  uro-MRI  tech-
iques.  They  require  a  surface  coil  covering  the  entire  upper
xcretory  tract.  Depending  on  the  patient’s  morphotype,  it
ill  not  be  performed  at  the  same  time.  There  are  two
ypes  of  uro-MRI:  with  (in  T1  weighting)  and  without  (in
2  weighting)  injection  of  contrast  agent.  If  there  is  no
t
w
awhite arrow); c: hypersignal from a typical left iliac adenopathy
ilatation  of  the  excretory  system,  this  must  be  potentiated
y  the  injection  of  Lasilix®.  If  the  option  of  T2  weighting
ithout  injection  is  chosen,  multiple  thin  slice  3D  acquisi-
ion  is  more  sensitive  for  detecting  small  lesions  on  native
lices  than  thick  slice  2D  acquisition.  MIP  reformation  pro-
ides  a  morphological  representation  of  the  entire  urinary
ree,  but  can  mask  small  masses.
omparison of CT and MRI for T stage
he  main  indication  for  CT  or  MRI  is  not  in  detecting  a  tumour
f  the  bladder  but  in  its  pre-treatment  staging,  mainly  in
ooking  for  any  perivesical  spread  for  the  stages  above  T2a
the  case  of  tumours  which  have  already  been  diagnosed  and
he  histological  type  and  location  of  which  is  known).
The  overall  reliability  of  MRI  is  greater  than  that  of  CT,
hich  is  explained  partly  by  the  better  contrast  resolution
nd  partly  by  its  ability  to  produce  slices  more  adapted
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Figure 6. MRI of a tumour of the dome of the bladder: a: T1-weighted GE following injection of gadolinium (30 seconds), axial plane.
Tumour of the dome (black arrow) combined with a small suspect right
below. Slowing of diffusion in the tumour of the dome with a clear hypo
Figure 7. MRI of an extensive bladder tumour, pT4. T2-weighted
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contours,  usually  uniform  content,  tissue  density  in  CT,  andSE, frontal plane. Large volume tumour mass of the dome involving
the wall of the sigmoid.
to  the  morphology  of  the  bladder,  allowing  tumours  of  the
dome  and  base  to  be  explored.  In  practice,  it  is  only  essen-
tial  if  extension  to  neighbouring  organs  is  suspected,  from
the  pT3b  stage.
Uro-CT  is  currently  the  most  reliable  technique  for
exploring  the  upper  urinary  tract  if  renal  function  is
satisfactory.
Lymph node extension
Morphological abnormality: increase in the
short axisMRI  and  CT  use  the  same  main  morphological  analysis
criterion  based  on  size  to  distinguish  lymph  nodes  from
i
i
t external iliac lymph node; b: diffusion sequence: ADC map  2 cm
signal.
denopathy.  Adenopathy  is  diagnosed  when  additional  tissue
as  formed  around  the  vascular  axes.
Normal  lymph  nodes  are  commonly  visible  on  a  routine
asis.  The  main  problem  is  to  deﬁne  the  size  beyond  which  a
ymph  node  is  considered  to  be  pathological.  There  has  been
 great  deal  of  work  on  this,  with  studies  reporting  ﬁgures
hat  vary  because  of  the  heterogeneity  of  the  equipment  and
he  protocols.  The  standard  value  is  deﬁned  as  the  value  of
he  shortest  axis,  taken  perpendicular  to  the  longest  axis
n  the  transverse  axial  plane,  or  the  minimal  axial  diameter
or  short  diameter).  The  ‘mean’  consensus  threshold  value
eyond  which  a  lymph  node  is  considered  to  be  pathologi-
al  is  10  mm  for  retroperitoneal  lymph  nodes  and  8  mm  for
elvic  cavity  lymph  nodes  [12].
This size  criterion  does  not  differentiate  an  inﬂammatory
denopathy  from  a  metastatic  adenopathy,  in  particular  if
he  lesion  is  small.  False  positives  are  however  a great  deal
arer  than  false  negatives  due  to  metastatic  invasion  into
ormal  size  lymph  nodes  or  even  micrometastases.
Diagnosis  is  very  easy  when  formations  are  voluminous,  if
here  are  many  of  them  and  in  different  stages  of  develop-
ent,  or  if  they  are  grouped  together  forming  a mass  with
 polycyclic  external  contour.  This  mass  can  cause  venous
ompression  or  even  thrombosis.  The  entire  vascular  axis
eing  pushed  aside  is  rarer.  When  the  mass  is  very  large
t  becomes  difﬁcult  to  differentiate  between  local  tissue
ecurrence,  a lymphatic  mass  and  invasion  of  the  muscle.
he  better  contrast  in  MRI  sequences  produces  this  distinc-
ion.
ignal abnormality
ithout  injection,  lymph  nodes  or  adenopathies  have  clearn  MRI  a  weak  to  intermediate  signal  in  T1  weighting  and  an
ntermediate  to  high  signal  in  a  T2-weighted  sequence,  con-
rasting  with  the  lack  of  signal  from  the  vessels  (except  for
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ow  phenomena).  The  contrast  agent  is  taken  up  intensely
nd  uniformly  in  CT  and  MRI.  Modiﬁcation  of  lymph  node
ensity  (or  of  the  signal)  possibly  indicates  the  node’s  struc-
ure  has  been  modiﬁed.  A  T1-weighted  sequence  is  used
o  look  for  adenopathy.  Uniform  adenopathies  have  the
ame  characteristics:  neither  the  density  value  nor  the  sig-
al  intensity  or  uptake  of  the  contrast  agent  is  sufﬁciently
iscriminating  to  distinguish  malignant  adenopathy  from
nﬂammatory  adenopathy  or  even  from  a  common  lymph
ode.
There  are  several  possibilities  when  the  content  found  is
eterogeneous:
sclerolipomatosis  is  commonplace  and  frequent  in  a  pelvic
or  retroperitoneal  lymph  node.  It  is  seen  as  more  or  less
considerable  central  hypodensity  or  a  hypersignal  on  a
T1-weighted  sequence,  with  an  intermediate  signal  on
a  T2-weighted  sequence.  It  does  not  become  enhanced l
igure 8. MRI of a large volume intravesical and intradiverticular tumo
ccupies the diverticulum and the invaded neck is clearly visible (black ar
reter being pushed aside by the cancerous diverticulum is clearly visib
rom the tumour in the bladder and diverticulum (white arrow). PresencC.  Roy
following  injection.  The  signal  is  cancelled  on  the
sequence  with  suppression  of  the  fat  signal;
necrosis  is  shown  by  a more  or  less  dense  centre  or  ﬂuid
signal  before  injection,  without  enhancement  after  injec-
tion,  but  with  more  or  less  regular  peripheral  uptake  of
contrast  agent.  Its  existence  provides  a  positive  predictive
value  of  100%  for  diagnosing  metastatic  adenopathies,
but  it  is  only  present  in  adenopathies  of  at  least  2  cm.
It  should  be  remembered  that  necrosis  is  also  observed  in
tuberculous  adenopathies;
an excellent  criterion  for  malignancy  is  the  existence  of
modiﬁcation  of  perilymphatic  fat  density  due  to  inﬁl-
tration,  which  indicates  extracapsular  spread  and  local
carcinosis;  it  is  however  rarely  observed.
The  sensitivity  and  speciﬁcity  values  reported  in  the
iterature depend  on  technical  parameters  (ﬁeld  of  view,
ur, stage pT3b: a: T2-weighted SE, frontal plane. The mass partially
row); b: T2-weighted SE, fat saturation, sagittal plane. The dilated
le (white arrow); c: diffusion sequence, axial plane. Hypersignal
e of left iliac adenopathy (white arrowhead).
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Figure 9. MRI of a bladder leiomyoma. T2-weighted SE, sagittal
plane. The mass gives a uniform hyposignal, indicating its muscle
nature. Note the lifting of the mucosa which is still normal, with an
obtuse contact angle (white arrow).
Figure 11. MRI of vesical endometriosis. T2-weighted SE, axial
plane. Clear hyposignal from the mass indicating its mainly ﬁbrous
nature. It is invading the bladder wall and gradually pushing back
the mucosa, producing an extravesical process (black arrow). It is
attracting the uterine cervix and the left ovary.
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tmatrix  size  and  slice  thickness  in  CT  and  MRI,  type  of
sequence  and  number  of  excitations  in  MRI,  etc.),  as  well
as  on  the  choice  of  diameter  threshold  above  which  a  lymph
node  is  considered  as  pathological.  Figures  estimating  the
reliability  of  CT  and  MRI  vary  widely,  with  rates  reported
of  67  to  97%  for  CT  and  77  to  98%  for  MRI.  The  negative
predictive  value  of  the  two  methods  is  still  low,  owing  to
micrometastases  in  normal  size  lymph  nodes  and  sensitivity
estimated  at  between  48  and  75%.  Based  on  this  crite-
rion  of  size,  the  overall  diagnostic  performance  of  MRI  is
no  better  than  that  of  CT  and  is  estimated  at  85%.  Four
per  cent  of  normal  volume  lymph  nodes  are  thought  to  be
metastatic.
Diffusion  imaging  is  currently  being  evaluated  for  lymph
node  extension  and  seems  promising  [13]  (Fig.  5c). s
Figure 10. MRI of a leiomyosarcoma of the bladder: a: T2-weighted 
occupies the entire bladder, with complete inﬁltration of the wall; b: T1onitoring following treatment
n  the  post-therapeutic  period,  MRI  is  the  examination  of
hoice  for  detecting  recurrence.  This  is  frequent  in  male
atients  treated  by  radical  cystoprostatectomy  or  in  women
reated  by  anterior  pelvectomy,  and  estimated  at  45%  in
ome  series  [14]. Isolated  pelvic  masses  appear  in  the
perative  bed,  or  more  often  associated  with  adenopathy.
hese  masses  invade  the  muscle  wall  and  the  remaining
rgans,  more  rarely  the  rectum.  Uro-MRI  is  also  useful  for
ssessing  ureterointestinal  anastomosis.  Lymph  node  related
ecurrence  is  primarily  pelvic,  and  secondly  retroperi-
oneal.  Dynamic  sequences  with  injection  and  the  diffusion
equence  are  the  most  useful.
SE, frontal plane. Heterogeneous hypersignal of the mass, which
-weighted SE after injection. The lesion is partly necrosed.
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linical forms
umour that has developed in a bladder
iverticulum
lice  imaging  provides  evidence  of  the  nature  of  the  tissue
wing  to  early  contrast  agent  uptake  (Fig.  8).  Locoregional
taging  is  more  precise  with  MRI  than  with  CT.
The  prognosis  is  very  poor,  with  less  than  10%  survival
t  5  years,  because  the  muscle  wall  of  the  diverticulum
s  thin  or  inexistent,  which  encourages  rapid  progres-
ion  of  the  tumour  from  a  superﬁcial  stage  to  a  stage
3b.
rachal tumour
rachal  tumours  make  up  approximately  0.2%  of  all  blad-
er  tumours.  Although  the  urachus  is  usually  covered  by  an
pithelium,  90%  of  these  cancers  are  adenocarcinomas,  and
re  usually  mucinous.  They  appear  to  arise  from  metaplasia
f  the  epithelium  of  the  urachus.
The  tumour  occurs  in  middle-aged  men  and  is  usually
ocated  in  the  juxtavesical  part  of  the  urachus.  It  grows
apidly.  Extension  to  the  bladder  occurs  early,  via  the  ante-
ior  surface  of  the  bladder,  then  affects  the  peritoneum
fter  crossing  the  retropubic  space  and  the  abdominal  wall.
symptomatic  and  insidious  at  the  onset,  these  adenocarci-
omas  are  discovered  in  80%  of  cases  at  a  late  stage  when
aematuria  or  a  hard  subpubic  mass  occurs,  or  when,  rarely,
 haemorrhagic  umbilical  ﬁstula  is  found.
The  topography  is  distinctively  suggestive:  a  medial  or
aramedial  mass  in  the  prevesical  space,  with  develop-
ent  predominantly  outside  the  bladder  upwards  along  the
rachus.
In  MRI,  a  T2-weighted  SE  sagittal  sequence  is  best  for
nalysing  the  topography  and  parietal  extension.
The  main  differential  diagnosis  is  an  infected  urachal
yst,  which  should  be  considered  when  the  clinical  symp-
oms  include  infection,  the  patient  is  young  and  there  is  no
ptake  of  the  contrast  agent  in  CT.  However,  if  the  adeno-
arcinoma  is  already  chronic,  it  appears  like  a  more  or  less
ecrosed  tumoral  mass.
on-epithelial tumours of the bladder
hese  tumours  constitute  about  3%  of  all  bladder  tumours
Figs.  9  and  10).  They  include  very  diverse  histological  types,
oth  benign  and  malignant.  Imaging  methods,  combined
ith  a  set  of  topographical  and  also  clinical  facts,  may  pro-
uce  the  diagnosis  of  a  suspected  non-epithelial  tumour.
ystoscopy  generally  provides  more  information,  but  the
eﬁnitive  diagnosis  is  often  made  from  histopathological
nalysis  of  the  ablated  material.
Leiomyoma  of  the  bladder  is  rare  (0.04—0.5%  of  all  blad-
er  tumours),  but  it  is  the  most  common  non-epithelial
ladder  tumour  making  up  almost  this  entire  group.
The  relationship  of  the  mass  to  the  bladder  is  best
nalysed  in  MRI  in  the  sagittal  and  frontal  planes.  Leiomy-
ma  is  diagnosed  when  the  mass  is  homogeneous,  giving  an
ntermediate  to  low  signal  in  a  T1-weighted  sequence  and
 hyposignal  in  a  T2-weighted  sequence.  More  rarely,  it  is
u
p
a
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eterogeneous,  with  zones  giving  a  high  signal  correspond-
ng  to  mucoid  or  ﬁbrohyaline  degeneration  (an  appearance
imilar  to  a  uterine  leiomyoma).  Following  injection,  it  is
ariably  enhanced.
esical endometriosis
he  bladder  is  the  most  common  site  of  endometriosis  in  the
rinary  tract,  followed  by  the  ureters  and  kidneys  (Fig.  11).
t  is  usually  a  question  of  simple  inﬁltration  of  the  serosa  or
f  small  disseminated  nodules,  more  rarely  a  vesical  mass.
t  favours  a location  on  the  dome  or  posterior  surface  of
he  bladder,  and  is  responsible  for  haematuria,  cyclical  with
enstruation,  and/or  dysuria.  It  occurs  in  women  during  the
eriod  of  reproductive  activity.
Cystoscopy  shows  submucosal  lesions,  similar  to  the
hocolate  or  bluish  cysts  described  around  the  ovary  in  coe-
ioscopy,  located  in  the  vesicouterine  pouch.
In  MRI,  this  mass  will  have  an  intermediate  to  low
ntensity  signal  in  T1  weighting,  often  with  small  areas  of
ypersignal  due  to  recent  haemorrhagic  foci.  Its  size  varies.
n  a  T2-weighted  sequence,  the  signal  is  mainly  of  low  inten-
ity  because  of  the  ﬁbrous  tissue,  with  or  without  small
reas  of  hypersignal  indicating  recent  haemorrhagic  pheno-
ena.  It  displaces  the  epithelium,  sometimes  the  seat  of
n  inﬂammatory  reaction  seen  as  a  hypersignal.  Its  external
ontours  are  irregular,  it  ﬁxes  on  and  invades  the  anterior
art  of  the  uterine  body,  and  its  morphology  is  pathog-
omonic.  It  is  almost  always  associated  with  other  sites  of
elvic  endometriosis.
TAKE-HOME  MESSAGES
• Dynamic  sequences  of  MRI  enable  better  analysis  of
the  bladder  wall  than  CT.
• MRI  is  superior  to  CT  for  locoregional  staging;  it  is
indicated  in  pre-treatment  staging  of  large  tumours.
• MRI  is  superior  to  CT  for  staging  an  atypical  lesion  and
in  some  cases  (endometriosis,  leiomyoma)  provides
a  deﬁnitive  diagnosis.
• Diffusion  imaging  is  particularly  sensitive  for  tumour
examination  and  staging.
• The  performance  of  CT  and  MRI  is  identical  for
investigating  lymph  nodes.
linical case
his  36-year-old  female  patient  complained  of  dysuria  that
he  had  had  for  about  1  year.  She  presented  with  an  episode
f  bacterial  cystitis  2  months  previously,  which  was  treated
ith  oral  antibiotic  therapy.  She  had  no  medical  or  obstetric
istory  (one  normal  pregnancy  10  years  previously).
The  clinical  and  pelvic  examinations  were  normal.  The
nly  physiological  abnormality  was  the  existence,  found
sing  a  test  strip,  of  microscopic  haematuria.  Cystoscopy,
erformed  in  another  centre,  only  showed  lifting  of  the
nterior  bladder  wall.  A  subpubic  (Fig.  12a)  and  endovaginal
Fig.  12b)  ultrasound  examination  was  undertaken.
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Figure 12. Subpubic (a) and endovaginal (b) ultrasound examination.
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Figure 13. a—g: MRI of the pelvis.
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MRI  of  the  pelvis  was  performed  (Fig.  13a—g).
Questions
1. What  additional  ultrasound  investigation  would  you  sug-
gest?
2.  Would  you  have  conducted  this  examination  in  the  ﬁrst
place?
3.  Give  details  of  the  different  MRI  sequences.
4.  What  might  have  improved  the  iconographic  quality?
5.  How  many  lesions  can  you  identify?  What  is  their  topog-
raphy?
6. What  diagnostic  hypotheses  can  you  suggest  and  which
one  would  you  choose?
Answers
1.  Doppler  examination  (no  vascularisation  was  detected).
2. Yes.
3. a  and  b:  T2  FSE;  c:  diffusion;  d:  ADC  mapping;  e:  T1
FAT-SAT;  f:  early  phase  T1  Gd;  g:  late  phase  T1Gd.
4. Injection  of  an  antispasmodic  such  as  Glucagen® to
reduce  intestinal  peristalsis,  the  origin  of  artefacts  (in
addition  to  respiratory  movements).
5. Two:  a  bladder  wall  mass  and  a  common  leiomyoma  of
the  uterus.
6. There  are  two  main  hypotheses:
• endometriosis,  but  the  signal  is  intermediate  on  T2,
homogeneous,  with  no  microcyst  or  continuity  with  the
uterus;  the  location  is  unusual  and  there  is  no  clinical
recrudescence  during  menstruation;  however  the  lesion
is  typically  submucosal,  raising  the  echogenic  border  of
the  epithelium;
• a  tumour  of  the  bladder  wall:
◦  a  phaeochromocytoma  and  a  haemangioma  are  elim-
inated  because  the  signal  does  not  concur,
◦  a  leiomyoma  of  the  bladder  wall  can  be  considered
in  view  of  the  low  signal,  the  reduction  in  diffusion
indicating  a  compact  lesion  with  little  intercellular
space,  the  homogeneous  nature  of  the  mass  with
poor  uptake  of  contrast  agent;  there  may  be  a  ﬁbrous
component  given  the  late  uptake  of  contrast  agent.
Final  diagnosis:  a  rare  benign  neuroﬁbroma  of  the  bladder
wall  (diagnosis  by  partial  cystectomy).
These  ﬁbromas  and  neuroﬁbromas  arise  from  the  vesi-
coprostatic  and  vesicovaginal  nerve  plexuses  close  to  the
trigone,  the  ureters  and  the  urethra.  They  are  encountered
almost  entirely  in  Von  Recklinghausen’s  ﬁbromatosis.  The
clinical  symptom  is  more  often  obstruction  than  haematuria.
Sarcomatous  degeneration  is  possible.  In  CT,  it  is  seen  as  a
not  very  dense  uniform  mass,  becoming  enhanced  following
injection  of  the  contrast  agent.  In  MRI,  the  signal  is  inter-
mediate  to  low  in  a  T1-weighted  sequence,  but  higher  than
the  signal  from  muscle.  In  T2-weighted  SE,  its  signal  is  inter-
mediate  to  high  and  slightly  higher  than  that  from  fat.  It  is
intensely  enhanced  on  injection.
A ganglioneuroma  is  exceptional,  readily  encountered  in
Von  Recklinghausen’s  disease.  It  is  a  benign,  slow  growing
[309
umour,  composed  of  nerve  ﬁbres  and  mature  ganglion  cells.
t  affects  children  and  adolescents.  It  locates  on  the  pos-
erior  wall  or  the  base  and  therefore  is  readily  revealed
hrough  urinary  obstruction.  Tumourous  calciﬁcations  are
resent  in  half  of  cases,  whereas  they  are  very  rare  in
euroﬁbromas.  Differential  histological  diagnosis  can  be  dif-
cult.
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